EMERYVILLE, Calif., November 07, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2024. EMERYVILLE ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Tuesday, NovaBay Pharmaceuticals Inc (NBY) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.10 or 18.18% from the prior close of $0.55. The stock opened ...

NovaBay (NBY) announces that the Company has accepted a revised transaction proposal from PRN Physician Recommended Nutriceuticals, LLC to ...

At close: November 5 at 4:00 PM EST ...

China Shineway Pharmaceutical Group Ltd. +0.00% +0.00% China Shineway Pharmaceutical Group Ltd.-16.08% +0.00% ...